Fig. 1: Antifungal agents treatment alleviated glucose metabolism related disorders in HFD-fed mice.
From: Abnormal proliferation of gut mycobiota contributes to the aggravation of Type 2 diabetes
a Fasted blood glucose, b Free blood glucose (6th week), c Cumulative food intake (5days recorded), d HOMA-IR, e OGTT and f AOC, g ITT, h Weight change, i Plasma triglyceride, j Plasma total cholesterol, LDL-C and HDL-C, k liver/body weight ratio, l plasma alanine trasaminase (ALT) and aspartate transminase (AST), m Plasma TNF-α, n Plasma LPS, o representative H & E-stain pictures of WAT tissue, and representative H & E-stain and oil-red stain pictures of liver tissue (Scale bars, 100 μm (n = 3 mice per group)). Data are presented as the mean ± standard error of the mean (SEM); n = 8 mice per group. Statistical analysis was done using one-way ANOVA followed by the Tukey post hoc test. *P < 0.05; **P < 0.01 vs HFD group, and #P < 0.05; ##P < 0.01 vs CD group.
